The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-1-(2-(Benzo[d][1,3]dioxol-5-yl)ethylsulfonyl)-N-hydroxypyrrolidine-2-carboxamide ID: ALA2385489
PubChem CID: 73354941
Max Phase: Preclinical
Molecular Formula: C14H18N2O6S
Molecular Weight: 342.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NO)[C@@H]1CCCN1S(=O)(=O)CCc1ccc2c(c1)OCO2
Standard InChI: InChI=1S/C14H18N2O6S/c17-14(15-18)11-2-1-6-16(11)23(19,20)7-5-10-3-4-12-13(8-10)22-9-21-12/h3-4,8,11,18H,1-2,5-7,9H2,(H,15,17)/t11-/m0/s1
Standard InChI Key: XYXRFODFDUOQKS-NSHDSACASA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
3.0057 -14.2716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6641 -14.7731 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3426 -14.3038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1071 -13.5143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2798 -13.4955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2136 -14.5079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6160 -13.9400 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0227 -15.3140 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8239 -14.1762 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6393 -15.6006 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.3658 -15.9933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0699 -15.5592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7963 -15.9519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8155 -15.6019 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2293 -16.3172 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8178 -16.7762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2219 -15.9063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4958 -15.5174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2478 -16.7360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5476 -17.1681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7421 -17.9676 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5627 -18.0297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8752 -17.2684 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
1 6 1 6
6 7 1 0
6 8 2 0
7 9 1 0
2 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
10 14 2 0
15 10 2 0
13 16 2 0
16 20 1 0
19 17 1 0
17 18 2 0
18 13 1 0
19 20 2 0
20 21 1 0
21 22 1 0
22 23 1 0
23 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 342.37Molecular Weight (Monoisotopic): 342.0886AlogP: 0.26#Rotatable Bonds: 5Polar Surface Area: 105.17Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.71CX Basic pKa: ┄CX LogP: -0.01CX LogD: -0.03Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.59Np Likeness Score: -0.94
References 1. Mori M, Massaro A, Calderone V, Fragai M, Luchinat C, Mordini A.. (2013) Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold., 4 (6): [PMID:24900710 ] [10.1021/ml300446a ]